Clinical significance of plasma VEGF value in ischemic stroke - research for biomarkers in ischemic stroke (REBIOS) study

[1]  T. Kitazono,et al.  Relationship Between Asian Dust and Ischemic Stroke: A Time-Stratified Case-Crossover Study , 2012, Stroke.

[2]  Adeline R. Whitney,et al.  Sublytic concentrations of Staphylococcus aureus Panton‐Valentine leukocidin alter human PMN gene expression and enhance bactericidal capacity , 2012, Journal of leukocyte biology.

[3]  J. Hata,et al.  Proteinuria and clinical outcomes after ischemic stroke , 2012, Neurology.

[4]  J. Hata,et al.  Prestroke Glycemic Control Is Associated With the Functional Outcome in Acute Ischemic Stroke: The Fukuoka Stroke Registry , 2011, Stroke.

[5]  P. He,et al.  Activation of the Central Histaminergic System is Involved in Hypoxia-Induced Stroke Tolerance in Adult Mice , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[6]  Gregory W Albers,et al.  Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials , 2010, The Lancet.

[7]  S. Koh,et al.  Serum VEGF levels in acute ischaemic strokes are correlated with long‐term prognosis , 2010, European journal of neurology.

[8]  M. Chopp,et al.  Angiopoietin1/TIE2 and VEGF/FLK1 Induced by MSC Treatment Amplifies Angiogenesis and Vascular Stabilization after Stroke , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[9]  Yusuke Nakamura,et al.  A nonsynonymous SNP in PRKCH (protein kinase C η) increases the risk of cerebral infarction , 2007, Nature Genetics.

[10]  Anindita Das,et al.  Hypercholesterolemia Enhances Tolerance to Lethal Systemic Hypoxia in Middle-Aged Mice: Possible Role of VEGF Downregulation in Brain , 2006, Molecular and Cellular Biochemistry.

[11]  P. Carmeliet,et al.  VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.

[12]  M. Kubo,et al.  Ten-Year Prognosis of Stroke and Risk Factors for Death in a Japanese Community: The Hisayama Study , 2003, Stroke.

[13]  K. Jin,et al.  VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. , 2003, The Journal of clinical investigation.

[14]  P. Carmeliet.  Angiogenesis in health and disease , 2003, Nature Medicine.

[15]  Hamid Soltanian-Zadeh,et al.  Correlation of VEGF and Angiopoietin Expression with Disruption of Blood–Brain Barrier and Angiogenesis after Focal Cerebral Ischemia , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[16]  M. Chopp,et al.  Vascular endothelial growth factor and angiopoietins in focal cerebral ischemia. , 2002, Trends in cardiovascular medicine.

[17]  M Chopp,et al.  VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. , 2000, The Journal of clinical investigation.

[18]  A. Słowik,et al.  Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic stroke. , 2000, Stroke.

[19]  M. Bernaudin,et al.  Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. , 2000, The American journal of pathology.

[20]  J. Krupiński,et al.  Vascular endothelial growth factor and its receptor, KDR, in human brain tissue after ischemic stroke. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[21]  Y. Olsson,et al.  Expression of Vascular Endothelial Growth Factor (VEGF) and its Receptors (Flt-1 and Flk-1) following Permanent and Transient Occlusion of the Middle Cerebral Artery in the Rat , 1998, Journal of neuropathology and experimental neurology.

[22]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[23]  Alan D. Lopez,et al.  Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study , 1997, The Lancet.

[24]  M. Fukui,et al.  VEGF and flt. Expression time kinetics in rat brain infarct. , 1996, Stroke.

[25]  David Lee Gordon,et al.  Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.

[26]  H. Dvorak,et al.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.